Ambulatory Care Pharmacy

Operational since 2005, Supernus Pharmaceuticals is a specialty pharmaceutical company that develops products and technologies for the treatment of central nervous system disorders. The company offers the ProScreen, ProPhile and OptiScreen technologies for lead selection and formulation optimization. It also provides oral controlled release solutions under the Microtrol, Solutrol and EnSoTrol brands. Supernus Pharmaceuticals' technology platform, Avert, reduces the abuse potential of formulations that deliver scheduled substances. In addition, it is involved in the clinical-stage development of drug candidates that can be used for the treatment of epilepsy, depression, anxiety, conduct disorder and Parkinson s disease. The company works in partnership with Afecta Pharmaceuticals and Rune Healthcare Limited.

Founded in 1996, TheraCom is a provider of comprehensive reimbursement, clinical, data collection and reporting solutions. It customizes its solutions for the biotechnology and pharmaceutical manufacturers to assure commercialization of their specialty products. The company works on behalf of the manufacturer and under the manufacturer s brand to deliver support services that will lead to the dispensing or distribution of the product. Based in Maryland, it provides clinical trial assistance, launch plan development assistance, market research assistance, support center services, distribution coordination, patient education and more. TheraCom is subsidiary of CVS Caremark Company. In August of 2001, the company joined AdvancePCS Inc.

Incorporated in 1989, Otsuka America Pharmaceutical is a health care company that commercializes its products throughout North America. It offers products under the ABILIFY Tablets1 and PLETAL Tablets2 brands. The company works in collaboration with Bristol-Myers Squibb, which co-develops and co-promotes ABILIFY. Otsuka America Pharmaceutical has also merged with Meretek Diagnostics to form the Meretek Diagnostics Group under the Medical Device Division of OAPI. It focuses on neuroscience, cardiovascular, oncologic and gastrointestinal therapeutic treatments. The company operates Otsuka Maryland Research Institute, which was established as a wholly-owned subsidiary of OAPI to research and develop a variety of health care products. Otsuka America Pharmaceutical is a part of Otsuka Pharmaceutical Group.